Pharmaceuticals

Roche weighs options for struggling diabetes-care business, including a sale

01 Feb 2017

Denmark’s Novo Nordisk to invest £115 mn in new research centre at Oxford

30 Jan 2017

Piramal acquires Mallinckrodt’s pain management drug portfolio for $203 million

30 Jan 2017

US FDA warns against high belladonna content in certain homeopathic products

30 Jan 2017

Mezzion Pharma sues Dr Reddy’s in US for ‘millions of dollars’

27 Jan 2017

Antibiotics, not dirty hospitals, the main cause of C. difficile epidemic

25 Jan 2017

Overuse of antibiotics like ciprofloxacin led to the outbreak of severe diarrhoea caused by C. difficile that hit headlines from 2006 onwards. The outbreak was stopped by substantially reducing use of ciprofloxacin and related antibiotics

Trump's 'America First' policy to maul Indian IT, pharma sectors

23 Jan 2017

Pharma industry seeks GST relaxations in the name of the poor

21 Jan 2017

AYUSH ministry ropes in ASCI to monitor misleading ads

21 Jan 2017

Superbugs may be spreading faster than thought: study

By By Jagdeep Worah | 20 Jan 2017

A family of superbugs known as carbapenem-resistant Enterobacteriaceae or CRE may be spreading more widely than previously thought – and India is notorious for this type of bacteria. By Jagdeep Worah

EpiPen rival Kaleo to offer Auvi-Q emergency allegery auto-injector to some at no cost

20 Jan 2017

Mallinckrodt to pay $100 mn to settle 'price-gouging' charges

20 Jan 2017

The US regulator says that Questcor Pharmaceuticals, which Mallinckrodt bought in 2014, illegally raised the price of its best-selling drug Acthar by 85,000 per cent and bought the rights to a cheaper competing drug to keep it out of the US market

Unused prescription drugs regularly sold on eBay: BBC Report

18 Jan 2017

Govt mulls capping stent prices under its employee healthcare scheme

17 Jan 2017

Govt dilutes NPPA’s inflation-linked drug pricing rule

17 Jan 2017

‘Superbug’ resistant to all treatments contracted in India claims victim in Nevada

17 Jan 2017

Japan’s Takeda to buy US cancer drug maker Ariad for $5.20 bn

10 Jan 2017

The deal will give Takeda two innovative precision drugs, including a leukemia drug with sales of $170-180 million last year, and Brigatinib, which could offset any loss of sales due to generic competition to its top-selling blood cancer drug Velcade

French drugmaker Ipsen to buy some oncology assets from Merrimack for $1 bn

09 Jan 2017

Aurobindo Pharma acquires Portuguese firm for Rs970 crore

09 Jan 2017

New US FDA drug approvals down to six-year low in 2016

03 Jan 2017

Gates Foundation to invest $50 mn in biotech firm Intarcia Therapeutics

30 Dec 2016

Sun Pharma completes acquisition of controlling stake in JSC Biosintez

30 Dec 2016

Johnson & Johnson in talks to buy commercial portfolio of Actelion

30 Dec 2016

US regulator orders divestitures in Boehringer-Sanofi asset swap deal

29 Dec 2016

US regulators grant conditional approval to Abbott’s acquisition of St. Jude Medical

28 Dec 2016

US antitrust regulators yesterday approved Abbott Laboratories proposed $25-billion acquisition of medical device maker St. Jude Medical Inc on condition that it divests two medical device businesses